The purpose of this study is to measure the APT signal in different locations of adult-type diffuse gliomas and assess its correlation with glioma grading, molecular profile (IDH-mutation and MGMT promoter methylation status), and survival. This evidence concerns the gene IDH1 and central nervous system cancer.